(NYSE: COR) Cencora's forecast annual revenue growth rate of 6.28% is not forecast to beat the US Medical Distribution industry's average forecast revenue growth rate of 7.26%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.1%.
Cencora's revenue in 2024 is $271,579,412,000.On average, 6 Wall Street analysts forecast COR's revenue for 2024 to be $58,295,264,946,925, with the lowest COR revenue forecast at $57,661,965,673,591, and the highest COR revenue forecast at $58,976,055,496,780. On average, 6 Wall Street analysts forecast COR's revenue for 2025 to be $61,646,987,724,935, with the lowest COR revenue forecast at $59,315,013,104,984, and the highest COR revenue forecast at $62,833,995,150,699.
In 2026, COR is forecast to generate $65,041,106,211,434 in revenue, with the lowest revenue forecast at $62,969,243,941,953 and the highest revenue forecast at $67,282,024,682,414.